Register to chat with like-minded investors on our interactive forums.

Get Started

KALA

KALA BIO (KALA)

KALA BIO Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:KALA

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next >>

Date	Time	Source	Headline	Symbol	Company
01/03/2020	4:13PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KALA	KALA BIO Inc
01/03/2020	4:13PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KALA	KALA BIO Inc
01/03/2020	4:13PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KALA	KALA BIO Inc
01/03/2020	4:13PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KALA	KALA BIO Inc
01/03/2020	4:12PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KALA	KALA BIO Inc
12/19/2019	4:05PM	Business Wire	Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:KALA	KALA BIO Inc
11/19/2019	4:05PM	Business Wire	Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:KALA	KALA BIO Inc
11/07/2019	4:09PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:KALA	KALA BIO Inc
11/07/2019	7:19AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KALA	KALA BIO Inc
11/07/2019	7:00AM	Business Wire	Kala Pharmaceuticals Reports Third Quarter 2019 Financial Results	NASDAQ:KALA	KALA BIO Inc
11/04/2019	4:30PM	Business Wire	Kala Pharmaceuticals to Report Third Quarter 2019 Financial Results and Host Conference Call	NASDAQ:KALA	KALA BIO Inc
10/21/2019	4:05PM	Business Wire	Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:KALA	KALA BIO Inc
10/15/2019	5:57PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KALA	KALA BIO Inc
10/15/2019	5:57PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KALA	KALA BIO Inc
09/19/2019	4:05PM	Business Wire	Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:KALA	KALA BIO Inc
08/29/2019	8:00AM	Business Wire	Kala Pharmaceuticals to Present at Two Upcoming Investor Conferences in September	NASDAQ:KALA	KALA BIO Inc
08/20/2019	4:05PM	Business Wire	Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:KALA	KALA BIO Inc
08/08/2019	4:07PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KALA	KALA BIO Inc
08/08/2019	4:01PM	Business Wire	Kala Pharmaceuticals Receives FDA Complete Response Letter for KPI-121 0.25% NDA & Plans to Respond with Data From STRIDE 3 T...	NASDAQ:KALA	KALA BIO Inc
08/06/2019	4:29PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:KALA	KALA BIO Inc
08/06/2019	7:06AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KALA	KALA BIO Inc
08/06/2019	7:00AM	Business Wire	Kala Pharmaceuticals Reports Second Quarter 2019 Financial Results	NASDAQ:KALA	KALA BIO Inc
07/30/2019	4:05PM	Business Wire	Kala Pharmaceuticals to Report Second Quarter 2019 Financial Results and Host Conference Call	NASDAQ:KALA	KALA BIO Inc
06/20/2019	4:05PM	Business Wire	Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:KALA	KALA BIO Inc
06/10/2019	4:07PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KALA	KALA BIO Inc
06/07/2019	4:04PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KALA	KALA BIO Inc
06/07/2019	4:04PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KALA	KALA BIO Inc
06/07/2019	4:04PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KALA	KALA BIO Inc
06/07/2019	4:03PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KALA	KALA BIO Inc
06/07/2019	4:02PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KALA	KALA BIO Inc

Showing the most relevant articles for your search:NASDAQ:KALA

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next >>

Therapeutic Solutions (PK)

Seafarer Exploration (PK)

NioCorp Developments

Trump Media and Technology

Fannie Mae (QB)

Bell Buckle (PK)

Marketing Worldwide (PK)

Anavex Life Sciences

Global Developments (PK)

Kraig Biocraft Laborator... (QB)

Virexit Technologies (PK)

Delayed Upgrade Clock